An Exploratory Pilot Study of Neuropsychological Performance in Two Huntington Disease Centers of Excellence Clinics

Abstract Objectives To describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington’s Disease Society of America Centers of Excellence (HDSA COE). In this exploratory pilot study, we used an empirically supported clinical neuropsychologic...

Full description

Saved in:
Bibliographic Details
Published in:Archives of clinical neuropsychology Vol. 39; no. 1; pp. 24 - 34
Main Authors: Rossetti, M Agustina, Anderson, Kendra M, Hay, Kaitlyn R, Del Bene, Victor A, Celka, Andrea S, Piccolino, Adam, Nelson Sheese, Amelia L, Huynh, Melissa, Zhu, Liang, Claassen, Daniel O, Furr Stimming, Erin, Considine, Ciaran M
Format: Journal Article
Language:English
Published: United States Oxford University Press 19-01-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract Objectives To describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington’s Disease Society of America Centers of Excellence (HDSA COE). In this exploratory pilot study, we used an empirically supported clinical neuropsychological battery to assess differences in cognitive performance between premanifest and manifest HD patient groups (compared with each other and normative expectations). Method Clinical data from 76 adult genetically confirmed patients referred for neuropsychological evaluations was retrospectively collected from two HDSA COEs. ANOVA and Chi-square tests were used to compare variables between pre-manifest (n = 14) and manifest (n = 62) groups for demographic, cognitive, neuropsychiatric, and disease severity variables. Results Our clinics serviced a disproportionate number of motor manifest patients. Six measures were excluded from analyses due to infrequent administration. The full WAIS-IV Digit Span was disproportionately administered to the manifest group. The premanifest group showed stronger cognitive performance with effect sizes in the large range on subtests of the WAIS-IV Digit Span, HVLT-R, SDMT, and verbal fluency. Conclusions This is the first study to assess an empirically supported neuropsychological research battery in a clinical setting with a relatively large sample size given the rarity of HD. The battery adequately captured areas of impairment across the disease spectrum. Application of the current battery with larger premanifest samples is warranted.
AbstractList To describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington's Disease Society of America Centers of Excellence (HDSA COE). In this exploratory pilot study, we used an empirically supported clinical neuropsychological battery to assess differences in cognitive performance between premanifest and manifest HD patient groups (compared with each other and normative expectations). Clinical data from 76 adult genetically confirmed patients referred for neuropsychological evaluations was retrospectively collected from two HDSA COEs. ANOVA and Chi-square tests were used to compare variables between pre-manifest (n = 14) and manifest (n = 62) groups for demographic, cognitive, neuropsychiatric, and disease severity variables. Our clinics serviced a disproportionate number of motor manifest patients. Six measures were excluded from analyses due to infrequent administration. The full WAIS-IV Digit Span was disproportionately administered to the manifest group. The premanifest group showed stronger cognitive performance with effect sizes in the large range on subtests of the WAIS-IV Digit Span, HVLT-R, SDMT, and verbal fluency. This is the first study to assess an empirically supported neuropsychological research battery in a clinical setting with a relatively large sample size given the rarity of HD. The battery adequately captured areas of impairment across the disease spectrum. Application of the current battery with larger premanifest samples is warranted.
OBJECTIVESTo describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington's Disease Society of America Centers of Excellence (HDSA COE). In this exploratory pilot study, we used an empirically supported clinical neuropsychological battery to assess differences in cognitive performance between premanifest and manifest HD patient groups (compared with each other and normative expectations).METHODClinical data from 76 adult genetically confirmed patients referred for neuropsychological evaluations was retrospectively collected from two HDSA COEs. ANOVA and Chi-square tests were used to compare variables between pre-manifest (n = 14) and manifest (n = 62) groups for demographic, cognitive, neuropsychiatric, and disease severity variables.RESULTSOur clinics serviced a disproportionate number of motor manifest patients. Six measures were excluded from analyses due to infrequent administration. The full WAIS-IV Digit Span was disproportionately administered to the manifest group. The premanifest group showed stronger cognitive performance with effect sizes in the large range on subtests of the WAIS-IV Digit Span, HVLT-R, SDMT, and verbal fluency.CONCLUSIONSThis is the first study to assess an empirically supported neuropsychological research battery in a clinical setting with a relatively large sample size given the rarity of HD. The battery adequately captured areas of impairment across the disease spectrum. Application of the current battery with larger premanifest samples is warranted.
Abstract Objectives To describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington’s Disease Society of America Centers of Excellence (HDSA COE). In this exploratory pilot study, we used an empirically supported clinical neuropsychological battery to assess differences in cognitive performance between premanifest and manifest HD patient groups (compared with each other and normative expectations). Method Clinical data from 76 adult genetically confirmed patients referred for neuropsychological evaluations was retrospectively collected from two HDSA COEs. ANOVA and Chi-square tests were used to compare variables between pre-manifest (n = 14) and manifest (n = 62) groups for demographic, cognitive, neuropsychiatric, and disease severity variables. Results Our clinics serviced a disproportionate number of motor manifest patients. Six measures were excluded from analyses due to infrequent administration. The full WAIS-IV Digit Span was disproportionately administered to the manifest group. The premanifest group showed stronger cognitive performance with effect sizes in the large range on subtests of the WAIS-IV Digit Span, HVLT-R, SDMT, and verbal fluency. Conclusions This is the first study to assess an empirically supported neuropsychological research battery in a clinical setting with a relatively large sample size given the rarity of HD. The battery adequately captured areas of impairment across the disease spectrum. Application of the current battery with larger premanifest samples is warranted.
Author Furr Stimming, Erin
Rossetti, M Agustina
Celka, Andrea S
Considine, Ciaran M
Zhu, Liang
Anderson, Kendra M
Del Bene, Victor A
Claassen, Daniel O
Huynh, Melissa
Hay, Kaitlyn R
Piccolino, Adam
Nelson Sheese, Amelia L
Author_xml – sequence: 1
  givenname: M Agustina
  orcidid: 0000-0003-0561-6405
  surname: Rossetti
  fullname: Rossetti, M Agustina
  email: say5ps@UVAhealth.org
– sequence: 2
  givenname: Kendra M
  surname: Anderson
  fullname: Anderson, Kendra M
  email: Kendra.M.Anderson@uth.tmc.edu
– sequence: 3
  givenname: Kaitlyn R
  surname: Hay
  fullname: Hay, Kaitlyn R
  email: kaitlyn.r.hay@vumc.org
– sequence: 4
  givenname: Victor A
  orcidid: 0000-0002-8562-5071
  surname: Del Bene
  fullname: Del Bene, Victor A
  email: victordelbene@uabmc.edu
– sequence: 5
  givenname: Andrea S
  surname: Celka
  fullname: Celka, Andrea S
  email: acsolomon@uabmc.edu
– sequence: 6
  givenname: Adam
  surname: Piccolino
  fullname: Piccolino, Adam
  email: adam.piccolino@state.mn.us
– sequence: 7
  givenname: Amelia L
  surname: Nelson Sheese
  fullname: Nelson Sheese, Amelia L
  email: amelia.nelsonsheese@unmc.edu
– sequence: 8
  givenname: Melissa
  surname: Huynh
  fullname: Huynh, Melissa
  email: mhuynh0494@gmail.com
– sequence: 9
  givenname: Liang
  surname: Zhu
  fullname: Zhu, Liang
  email: zljiau@gmail.com
– sequence: 10
  givenname: Daniel O
  surname: Claassen
  fullname: Claassen, Daniel O
  email: daniel.claassen@vumc.org
– sequence: 11
  givenname: Erin
  surname: Furr Stimming
  fullname: Furr Stimming, Erin
  email: Erin.E.Furr@uth.tmc.edu
– sequence: 12
  givenname: Ciaran M
  surname: Considine
  fullname: Considine, Ciaran M
  email: ciaran.considine@vumc.org
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37530515$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1PAjEURRuDkQ_dujRd6gJop1NalgRRTIiSiOvJo9PBmqEd206Ef-8Q0Lhz9e7ivJub00Ut66xG6JqSASVjNgSvSmOHoCAnPD1DHSoF63OZstaf3EbdED4IIZzS5AK1meCsybyD4sTi2a4qnYfo_B4vTekifo11vseuwM-69q4Ke_XuSrcxCkq81L5wfgtWaWwsXn05PK9tNHYTncX3JmgIGk-1jdqHQ8dsp3RZ6gM_bbYaFS7ReQFl0Fen20NvD7PVdN5fvDw-TSeLvmLJOPYpG0nIBVsrNRJ5IURCCyAqJ4KkUuqUJVySNQigIGQxBi4SIgkQOhY0zUcJ66HbY2_l3WetQ8y2JhzGgNWuDlkiU07JKOG8QQdHVHkXgtdFVnmzBb_PKMkOprOj6exkunm4OXXX663Of_EftQ1wdwRcXf1X9g3L9Yyl
CitedBy_id crossref_primary_10_1080_13854046_2023_2267789
Cites_doi 10.1212/WNL.44.12.2308
10.1037/neu0000134
10.1002/ana.410410521
10.1093/arclin/11.4.295
10.1001/jamaneurol.2019.2368
10.1002/mds.25964
10.1111/j.1532-5415.2005.53221.x
10.1037/a0020937
10.1016/j.cortex.2017.07.017
10.1007/s40737-020-00202-8
10.1016/j.jns.2005.07.007
10.1177/23982128211007769
10.3389/fneur.2021.667420
10.1016/S1474-4422(10)70276-3
10.1002/mdc3.12388
10.1016/j.jamda.2015.06.017
10.1136/jnnp-2011-301940
10.1093/arclin/acx021
10.1016/j.parkreldis.2016.06.023
10.1093/arclin/acy027
10.1002/mds.27227
10.1177/1073191111428764
10.1212/WNL.0b013e3181eccfa2
10.1016/S1474-4422(13)70088-7
10.1093/arclin/acaa026
10.1002/mds.27653
10.1093/arclin/acw025
10.1016/S1474-4422(18)30391-0
10.1002/hbm.21449
10.1136/jnnp.2007.128728
10.1016/j.neubiorev.2011.06.002
10.1097/01.wnn.0000152205.79033.73
10.1016/j.gaitpost.2016.07.014
10.1016/j.acn.2005.02.002
10.1093/sleep/33.6.781
10.1038/nrneurol.2014.24
10.1093/arclin/acs109
10.1016/j.neuropsychologia.2006.12.015
10.1002/mds.25864
10.1016/j.biopsych.2006.11.034
10.1017/S1355617716000321
10.1212/WNL.0000000000004743
10.1136/jnnp.74.1.120
10.1002/mds.21920
ContentType Journal Article
Copyright The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2023
The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2023
– notice: The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1093/arclin/acad054
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Psychology
EISSN 1873-5843
EndPage 34
ExternalDocumentID 10_1093_arclin_acad054
37530515
10.1093/arclin/acad054
Genre Journal Article
GroupedDBID ---
--K
.2P
.I3
.ZR
0R~
0SF
1B1
1RT
1TH
1~5
23M
4.4
48X
4G.
53G
5GY
5VS
5WD
6.Y
6I.
7-5
70D
AABZA
AACTN
AACZT
AAEDT
AAEDW
AAFTH
AAIKJ
AAJKP
AAJQQ
AALRI
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQFI
AAQXK
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWDT
AAXUO
ABEUO
ABIVO
ABIXL
ABJNI
ABKDP
ABMAC
ABNHQ
ABNKS
ABPTD
ABQLI
ABQNK
ABSAR
ABSMQ
ABWST
ABXVV
ABZBJ
ACFRR
ACGFS
ACHQT
ACIUM
ACPQN
ACUFI
ACUTJ
ACUTO
ACYHN
ACZBC
ADBBV
ADEYI
ADEZE
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADMUD
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADVLN
ADYVW
ADZXQ
AEGPL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AEXQZ
AFFZL
AFIYH
AFOFC
AFSHK
AFXAL
AFXEN
AFYAG
AGHFR
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHHHB
AHXPO
AIJHB
AITUG
AJEEA
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATGXG
AVNTJ
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
BZKNY
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBD
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
EO8
EO9
F5P
F9B
FDB
FECEO
FEDTE
FGOYB
FIRID
FLUFQ
FOEOM
FOTVD
FQBLK
G-2
G-Q
GAUVT
GJXCC
H13
H5~
HAR
HEG
HMK
HMO
HMW
HVGLF
HW0
HZ~
IHE
IOX
IXB
J21
JXSIZ
KAQDR
KBUDW
KC5
KOP
KSI
KSN
M-Z
M29
M39
M3V
M41
M49
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOMLY
NOYVH
NQ-
NU-
NVLIB
O-L
O0~
O9-
OAUYM
OAWHX
OBH
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
OZT
O~Y
P2P
P6G
PAFKI
PB-
PEELM
Q1.
Q5Y
QBD
R2-
RD5
RIG
ROL
ROX
ROZ
RPZ
RUSNO
RW1
RXO
SAE
SDG
SDP
SPS
SSZ
SV3
TEORI
TJX
TMA
TN5
WUQ
X7H
YAYTL
YKOAZ
YXANX
ZCA
~91
ABEJV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c329t-1368ad73bcc67df7721fa0cd070488e432580ba7a1a78f9a572080a019714d623
ISSN 1873-5843
IngestDate Fri Oct 25 09:50:13 EDT 2024
Thu Sep 12 16:49:12 EDT 2024
Sat Nov 02 12:16:42 EDT 2024
Wed Aug 28 03:16:11 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Movement disorder
Huntington disease
Assessment
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/pages/standard-publication-reuse-rights)
The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c329t-1368ad73bcc67df7721fa0cd070488e432580ba7a1a78f9a572080a019714d623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0561-6405
0000-0002-8562-5071
PMID 37530515
PQID 2845106255
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2845106255
crossref_primary_10_1093_arclin_acad054
pubmed_primary_37530515
oup_primary_10_1093_arclin_acad054
PublicationCentury 2000
PublicationDate 2024-01-19
PublicationDateYYYYMMDD 2024-01-19
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-19
  day: 19
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Archives of clinical neuropsychology
PublicationTitleAlternate Arch Clin Neuropsychol
PublicationYear 2024
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 2024012214450404000_ref19
Schroeder (2024012214450404000_ref49) 2012; 19
Baake (2024012214450404000_ref1) 2017; 95
Reilmann (2024012214450404000_ref40) 2019; 18
2024012214450404000_ref53
Hamilton (2024012214450404000_ref18) 2003; 74
Buysse (2024012214450404000_ref7) 2010; 33
Papoutsi (2024012214450404000_ref33) 2014; 29
2024012214450404000_ref44a
Tabrizi (2024012214450404000_ref60) 2013; 12
Penney (2024012214450404000_ref37) 1997; 41
Roebuck-Spencer (2024012214450404000_ref42) 2017; 32
Duff (2024012214450404000_ref14) 2010; 75
Wechsler (2024012214450404000_ref61) 2008
2024012214450404000_ref29
Salehinejad (2024012214450404000_ref45) 2021; 5
Ready (2024012214450404000_ref39) 2008; 23
Stout (2024012214450404000_ref57) 2014; 29
Beglinger (2024012214450404000_ref2) 2005; 18
Sieck (2024012214450404000_ref51) 2013; 28
Tabrizi (2024012214450404000_ref59) 2011; 10
2024012214450404000_ref62
Schumacher-Kuiper (2024012214450404000_ref50) 2021; 8
Henley (2024012214450404000_ref20) 2012; 36
Kroenke (2024012214450404000_ref23) 2009; 50
Morley (2024012214450404000_ref31) 2015; 16
Brandt (2024012214450404000_ref4) 2001
Hergert (2024012214450404000_ref21) 2021; 36
Eddy (2024012214450404000_ref15) 2015; 29
Cummings (2024012214450404000_ref11) 1994; 44
Fritz (2024012214450404000_ref16) 2016; 49
Schobel (2024012214450404000_ref48) 2017; 89
Maiman (2024012214450404000_ref27) 2019; 34
Deckel (2024012214450404000_ref12) 1996; 11
Golden (2024012214450404000_ref17) 2002
Scahill (2024012214450404000_ref47) 2013; 34
Duff (2024012214450404000_ref13) 2007; 62
Reitan (2024012214450404000_ref41) 1956
Ross (2024012214450404000_ref43) 2014; 10
Labuschagne (2024012214450404000_ref24) 2016; 22
Zenisek (2024012214450404000_ref64) 2016; 31
Bush (2024012214450404000_ref6) 2005; 20
Mestre (2024012214450404000_ref28) 2018; 33
Peinemann (2024012214450404000_ref36) 2005; 239
2024012214450404000_ref62a
Quinn (2024012214450404000_ref38) 2016; 31
2024012214450404000_ref3
Stout (2024012214450404000_ref56) 2011; 25
Smith (2024012214450404000_ref52) 1973
2024012214450404000_ref8
Landwehrmeyer (2024012214450404000_ref25) 2017; 4
Mills (2024012214450404000_ref30) 2020; 35
Tabrizi (2024012214450404000_ref58) 2021; 92
2024012214450404000_ref9
Sathe (2024012214450404000_ref46) 2021; 12
2024012214450404000_ref44
Solomon (2024012214450404000_ref54) 2007; 45
Paulsen (2024012214450404000_ref35) 2008; 79
Nasreddine (2024012214450404000_ref32) 2005; 53
Yohrling (2024012214450404000_ref63) 2020; 94
Bruzelius (2024012214450404000_ref5) 2019; 34
Stout (2024012214450404000_ref55) 2012; 83
Langbehn (2024012214450404000_ref26) 2019; 76
References_xml – volume: 44
  start-page: 2308
  issue: 12
  year: 1994
  ident: 2024012214450404000_ref11
  article-title: The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia
  publication-title: Neurology
  doi: 10.1212/WNL.44.12.2308
  contributor:
    fullname: Cummings
– volume: 29
  start-page: 268
  issue: 2
  year: 2015
  ident: 2024012214450404000_ref15
  article-title: Cognitive deficits predict poorer functional capacity in Huntington’s disease: But what is being measured?
  publication-title: Neuropsychology
  doi: 10.1037/neu0000134
  contributor:
    fullname: Eddy
– volume: 41
  start-page: 689
  issue: 5
  year: 1997
  ident: 2024012214450404000_ref37
  article-title: CAG repeat number governs the development rate of pathology in Huntington's disease
  publication-title: Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society
  doi: 10.1002/ana.410410521
  contributor:
    fullname: Penney
– volume: 11
  start-page: 295
  issue: 4
  year: 1996
  ident: 2024012214450404000_ref12
  article-title: Evidence of a neurologically based “denial of illness” in patients with Huntington's disease
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1093/arclin/11.4.295
  contributor:
    fullname: Deckel
– volume: 76
  start-page: 1375
  issue: 11
  year: 2019
  ident: 2024012214450404000_ref26
  article-title: Association of CAG repeats with long-term progression in Huntington disease
  publication-title: JAMA Neurology
  doi: 10.1001/jamaneurol.2019.2368
  contributor:
    fullname: Langbehn
– volume: 29
  start-page: 1281
  issue: 10
  year: 2014
  ident: 2024012214450404000_ref57
  article-title: HD-CAB: A cognitive assessment battery for clinical trials in Huntington’s disease1,2,3
  publication-title: Movement Disorders
  doi: 10.1002/mds.25964
  contributor:
    fullname: Stout
– volume: 53
  start-page: 695
  issue: 4
  year: 2005
  ident: 2024012214450404000_ref32
  article-title: The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment
  publication-title: Journal of the American Geriatrics Society
  doi: 10.1111/j.1532-5415.2005.53221.x
  contributor:
    fullname: Nasreddine
– volume: 25
  start-page: 1
  issue: 1
  year: 2011
  ident: 2024012214450404000_ref56
  article-title: Neurocognitive signs in prodromal Huntington disease
  publication-title: Neuropsychology
  doi: 10.1037/a0020937
  contributor:
    fullname: Stout
– volume: 95
  start-page: 51
  year: 2017
  ident: 2024012214450404000_ref1
  article-title: Cognitive decline in Huntington’s disease expansion gene carriers
  publication-title: Cortex
  doi: 10.1016/j.cortex.2017.07.017
  contributor:
    fullname: Baake
– volume-title: The Clinical Neuropsychologist
  ident: 2024012214450404000_ref3
– volume: 8
  start-page: 61
  issue: 1
  year: 2021
  ident: 2024012214450404000_ref50
  article-title: Is there a relation between caregiver burden and cognitive dysfunction in Huntington’s disease?
  publication-title: Journal of Psychosocial Rehabilitation and Mental Health
  doi: 10.1007/s40737-020-00202-8
  contributor:
    fullname: Schumacher-Kuiper
– volume: 239
  start-page: 11
  issue: 1
  year: 2005
  ident: 2024012214450404000_ref36
  article-title: Executive dysfunction in early stages of Huntington’s disease is associated with striatal and insular atrophy: A neuropsychological and voxel-based morphometric study
  publication-title: Journal of the Neurological Sciences
  doi: 10.1016/j.jns.2005.07.007
  contributor:
    fullname: Peinemann
– volume: 36
  start-page: 1426
  issue: 8
  year: 2021
  ident: 2024012214450404000_ref21
  article-title: Predictors of caregiver burden in Huntington’s disease
  publication-title: Archives of Clinical Neuropsychology
  contributor:
    fullname: Hergert
– volume: 5
  start-page: 239821282110077
  year: 2021
  ident: 2024012214450404000_ref45
  article-title: Hot and cold executive functions in the brain: A prefrontal-cingular network
  publication-title: Brain and Neuroscience Advances
  doi: 10.1177/23982128211007769
  contributor:
    fullname: Salehinejad
– volume: 12
  start-page: 1190
  year: 2021
  ident: 2024012214450404000_ref46
  article-title: Enroll-HD: An integrated clinical research platform and worldwide observational study for Huntington’s disease
  publication-title: Frontiers in Neurology
  doi: 10.3389/fneur.2021.667420
  contributor:
    fullname: Sathe
– volume: 10
  start-page: 31
  issue: 1
  year: 2011
  ident: 2024012214450404000_ref59
  article-title: Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: The 12-month longitudinal analysis
  publication-title: The Lancet Neurology
  doi: 10.1016/S1474-4422(10)70276-3
  contributor:
    fullname: Tabrizi
– volume: 4
  start-page: 212
  issue: 2
  year: 2017
  ident: 2024012214450404000_ref25
  article-title: Data analytics from Enroll-HD, a global clinical research platform for Huntington’s disease
  publication-title: Movement Disorders Clinical Practice
  doi: 10.1002/mdc3.12388
  contributor:
    fullname: Landwehrmeyer
– volume: 16
  start-page: 731
  issue: 9
  year: 2015
  ident: 2024012214450404000_ref31
  article-title: Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference
  publication-title: Journal of the American Medical Directors Association
  doi: 10.1016/j.jamda.2015.06.017
  contributor:
    fullname: Morley
– volume: 83
  start-page: 687
  issue: 7
  year: 2012
  ident: 2024012214450404000_ref55
  article-title: Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease
  publication-title: Journal of Neurology, Neurosurgery & Psychiatry
  doi: 10.1136/jnnp-2011-301940
  contributor:
    fullname: Stout
– volume: 50
  start-page: 613
  issue: 6
  year: 2009
  ident: 2024012214450404000_ref23
  article-title: An ultra-brief screening scale for anxiety and depression: The PHQ–4
  publication-title: Psychosomatics
  contributor:
    fullname: Kroenke
– volume: 32
  start-page: 491
  issue: 4
  year: 2017
  ident: 2024012214450404000_ref42
  article-title: Cognitive screening tests versus comprehensive neuropsychological test batteries: A National Academy of neuropsychology education paper
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1093/arclin/acx021
  contributor:
    fullname: Roebuck-Spencer
– volume: 31
  start-page: 46
  year: 2016
  ident: 2024012214450404000_ref38
  article-title: A randomized, controlled trial of a multi-modal exercise intervention in Huntington’s disease
  publication-title: Parkinsonism & Related Disorders
  doi: 10.1016/j.parkreldis.2016.06.023
  contributor:
    fullname: Quinn
– ident: 2024012214450404000_ref62
– volume: 34
  start-page: 259
  issue: 2
  year: 2019
  ident: 2024012214450404000_ref27
  article-title: Reliable digit span: Does it adequately measure suboptimal effort in an adult epilepsy population?
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1093/arclin/acy027
  contributor:
    fullname: Maiman
– volume: 33
  start-page: 187
  issue: 2
  year: 2018
  ident: 2024012214450404000_ref28
  article-title: Rating scales for cognition in Huntington’s disease: Critique and recommendations
  publication-title: Movement Disorders
  doi: 10.1002/mds.27227
  contributor:
    fullname: Mestre
– ident: 2024012214450404000_ref9
– volume-title: Hopkins verbal learning test--revised: Professional manual
  year: 2001
  ident: 2024012214450404000_ref4
  contributor:
    fullname: Brandt
– ident: 2024012214450404000_ref44
– volume-title: WAIS-IV: Wechsler adult intelligence scale
  year: 2008
  ident: 2024012214450404000_ref61
  contributor:
    fullname: Wechsler
– ident: 2024012214450404000_ref62a
– volume: 19
  start-page: 21
  issue: 1
  year: 2012
  ident: 2024012214450404000_ref49
  article-title: Reliable digit span: A systematic review and cross-validation study
  publication-title: Assessment
  doi: 10.1177/1073191111428764
  contributor:
    fullname: Schroeder
– volume: 75
  start-page: 500
  issue: 6
  year: 2010
  ident: 2024012214450404000_ref14
  article-title: Mild cognitive impairment in prediagnosed Huntington disease
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181eccfa2
  contributor:
    fullname: Duff
– volume: 12
  start-page: 637
  issue: 7
  year: 2013
  ident: 2024012214450404000_ref60
  article-title: Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: Analysis of 36-month observational data
  publication-title: The Lancet Neurology
  doi: 10.1016/S1474-4422(13)70088-7
  contributor:
    fullname: Tabrizi
– volume-title: Symbol digit modalities test
  year: 1973
  ident: 2024012214450404000_ref52
  contributor:
    fullname: Smith
– volume-title: The Clinical Neuropsychologist
  ident: 2024012214450404000_ref8
– volume: 35
  start-page: 671
  issue: 6
  year: 2020
  ident: 2024012214450404000_ref30
  article-title: Cognitive and motor norms for Huntington’s disease
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1093/arclin/acaa026
  contributor:
    fullname: Mills
– volume: 92
  start-page: A19
  issue: Suppl 1
  year: 2021
  ident: 2024012214450404000_ref58
  article-title: F01 development of the Huntington’s disease integrated staging system (HD-ISS)
  publication-title: Journal of Neurology, Neurosurgery & Psychiatry
  contributor:
    fullname: Tabrizi
– volume: 34
  start-page: 858
  issue: 6
  year: 2019
  ident: 2024012214450404000_ref5
  article-title: Huntington’s disease in the United States: Variation by demographic and socioeconomic factors
  publication-title: Movement Disorders
  doi: 10.1002/mds.27653
  contributor:
    fullname: Bruzelius
– volume-title: Journal of clinical and experimental neuropsychology
  ident: 2024012214450404000_ref53
– volume-title: Stroop color and word test: A manual for clinical and experimental uses
  year: 2002
  ident: 2024012214450404000_ref17
  contributor:
    fullname: Golden
– volume: 31
  start-page: 426
  issue: 5
  year: 2016
  ident: 2024012214450404000_ref64
  article-title: Prevalence of below-criterion reliable digit span scores in a clinical sample of older adults
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1093/arclin/acw025
  contributor:
    fullname: Zenisek
– volume: 18
  start-page: 165
  issue: 2
  year: 2019
  ident: 2024012214450404000_ref40
  article-title: Safety and efficacy of pridopidine in patients with Huntington’s disease (PRIDE-HD): A phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
  publication-title: The Lancet Neurology
  doi: 10.1016/S1474-4422(18)30391-0
  contributor:
    fullname: Reilmann
– volume: 34
  start-page: 519
  issue: 3
  year: 2013
  ident: 2024012214450404000_ref47
  article-title: Clinical impairment in premanifest and early Huntington’s disease is associated with regionally specific atrophy
  publication-title: Human Brain Mapping
  doi: 10.1002/hbm.21449
  contributor:
    fullname: Scahill
– volume: 79
  start-page: 874
  issue: 8
  year: 2008
  ident: 2024012214450404000_ref35
  article-title: Detection of Huntington’s disease decades before diagnosis: The predict-HD study
  publication-title: Journal of Neurology, Neurosurgery & Psychiatry
  doi: 10.1136/jnnp.2007.128728
  contributor:
    fullname: Paulsen
– volume: 36
  start-page: 237
  issue: 1
  year: 2012
  ident: 2024012214450404000_ref20
  article-title: Emotion recognition in Huntington’s disease: A systematic review
  publication-title: Neuroscience & Biobehavioral Reviews
  doi: 10.1016/j.neubiorev.2011.06.002
  contributor:
    fullname: Henley
– volume: 18
  start-page: 102
  issue: 2
  year: 2005
  ident: 2024012214450404000_ref2
  article-title: White matter volume and cognitive dysfunction in early Huntington’s disease
  publication-title: Cognitive and Behavioral Neurology
  doi: 10.1097/01.wnn.0000152205.79033.73
  contributor:
    fullname: Beglinger
– volume: 49
  start-page: 283
  year: 2016
  ident: 2024012214450404000_ref16
  article-title: Motor-cognitive dual-task deficits in individuals with early-mid stage Huntington disease
  publication-title: Gait & Posture
  doi: 10.1016/j.gaitpost.2016.07.014
  contributor:
    fullname: Fritz
– volume: 20
  start-page: 419
  issue: 4
  year: 2005
  ident: 2024012214450404000_ref6
  article-title: Symptom validity assessment: Practice issues and medical necessity NAN Policy & Planning Committee
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1016/j.acn.2005.02.002
  contributor:
    fullname: Bush
– volume: 33
  start-page: 781
  issue: 6
  year: 2010
  ident: 2024012214450404000_ref7
  article-title: Development and validation of patientreported outcome measures for sleep disturbance and sleeprelated impairments
  publication-title: Sleep
  doi: 10.1093/sleep/33.6.781
  contributor:
    fullname: Buysse
– ident: 2024012214450404000_ref29
– volume: 94
  issue: 15 Supplement
  year: 2020
  ident: 2024012214450404000_ref63
  article-title: Prevalence of Huntington’s disease in the US (954)
  publication-title: Neurology
  contributor:
    fullname: Yohrling
– volume-title: HRNES: Manual
  ident: 2024012214450404000_ref44a
– volume: 10
  start-page: 204
  issue: 4
  year: 2014
  ident: 2024012214450404000_ref43
  article-title: Huntington disease: Natural history, biomarkers and prospects for therapeutics
  publication-title: Nature Reviews Neurology 2014 10:4
  doi: 10.1038/nrneurol.2014.24
  contributor:
    fullname: Ross
– start-page: 134
  volume-title: Trail making test: Manual for administration, scoring and interpretation
  year: 1956
  ident: 2024012214450404000_ref41
  contributor:
    fullname: Reitan
– volume: 28
  start-page: 135
  issue: 2
  year: 2013
  ident: 2024012214450404000_ref51
  article-title: Symptom validity test performance in the Huntington disease clinic
  publication-title: Archives of Clinical Neuropsychology
  doi: 10.1093/arclin/acs109
  contributor:
    fullname: Sieck
– volume: 45
  start-page: 1767
  issue: 8
  year: 2007
  ident: 2024012214450404000_ref54
  article-title: Verbal episodic memory declines prior to diagnosis in Huntington’s disease
  publication-title: Neuropsychologia
  doi: 10.1016/j.neuropsychologia.2006.12.015
  contributor:
    fullname: Solomon
– ident: 2024012214450404000_ref19
– volume: 29
  start-page: 673
  issue: 5
  year: 2014
  ident: 2024012214450404000_ref33
  article-title: The cognitive burden in Huntington's disease: Pathology, phenotype, and mechanisms of compensation
  publication-title: Movement Disorders
  doi: 10.1002/mds.25864
  contributor:
    fullname: Papoutsi
– volume: 62
  start-page: 1341
  issue: 12
  year: 2007
  ident: 2024012214450404000_ref13
  article-title: Psychiatric symptoms in Huntington’s disease before diagnosis: The predict-HD study
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2006.11.034
  contributor:
    fullname: Duff
– volume: 22
  start-page: 595
  issue: 6
  year: 2016
  ident: 2024012214450404000_ref24
  article-title: Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington’s disease
  publication-title: Journal of the International Neuropsychological Society
  doi: 10.1017/S1355617716000321
  contributor:
    fullname: Labuschagne
– volume: 89
  start-page: 2495
  issue: 24
  year: 2017
  ident: 2024012214450404000_ref48
  article-title: Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000004743
  contributor:
    fullname: Schobel
– volume: 74
  start-page: 120
  issue: 1
  year: 2003
  ident: 2024012214450404000_ref18
  article-title: Behavioural abnormalities contribute to functional decline in Huntington’s disease
  publication-title: Journal of Neurology, Neurosurgery & Psychiatry
  doi: 10.1136/jnnp.74.1.120
  contributor:
    fullname: Hamilton
– volume: 23
  start-page: 721
  issue: 5
  year: 2008
  ident: 2024012214450404000_ref39
  article-title: Patient and caregiver quality of life in Huntington's disease
  publication-title: Movement Disorders
  doi: 10.1002/mds.21920
  contributor:
    fullname: Ready
SSID ssj0005112
Score 2.4421048
Snippet Abstract Objectives To describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington’s Disease...
To describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington's Disease Society of America...
OBJECTIVESTo describe the characteristics of patients receiving a clinical referral for neuropsychological evaluation in two Huntington's Disease Society of...
SourceID proquest
crossref
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
StartPage 24
SubjectTerms Adult
Humans
Huntington Disease - complications
Huntington Disease - psychology
Neuropsychological Tests
Pilot Projects
Retrospective Studies
Title An Exploratory Pilot Study of Neuropsychological Performance in Two Huntington Disease Centers of Excellence Clinics
URI https://www.ncbi.nlm.nih.gov/pubmed/37530515
https://search.proquest.com/docview/2845106255
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9tAEF4cB0oupU1fTh9sS6EHIWJpJa18VGoXX1JC64bcxGpXCgKzCrFMm3-fWc1aD0xoeuhFGLGSkObzfDOz8yDkM5Can8Uyc4XKchcYX7ozP5NuGIpQyUhEOBtw-ZN_v4rni2AxGu3Gknbn_quk4RzI2lTO_oO025vCCfgNMocjSB2Oj5J7oh3Mq8Pt84tyXdVNtmCzld704rgZKL2LXulAqZ3V78pZ4vwI03Fjjhs4TRTY1PqaRMQ_TbTfrMeuopu-hdtvZduWXerBY9so_g9g6LzGhIJzJ7k2k8V0yxNJU3eDWQHAB-pW9EK3AtMNzNifO91lPc7ztXOW2_Td0mxI2GCtDWz4JhnG7anPBwomkbdQWcecuWBAsb42x9ZIA9Ra1Rz0SB4DqHv0ga21AHfrsiFJKdQ0DDqqbBMYH158QA590HnhmBwmZ1eXl12-EVi2bddQdorXndqrBlbRoNJyz-FpDJ_VM_LUeiw0Qag9J6NcH5Mn5zYn45gctRx694LUiaY9-NEGfrSBH60Kug8_2oMfLTUF-NEOftTCj1r4mXt08KMWfi_Jr2-L1delawd7uJL5s9r1WBQLxVkmZcRVAQ6eV4ipVEA_wCd5wPwwnmaCC0_wuJiJkPvg2AjwRrgXKDDYX5GxrnT-hlDuC8aV8hT49YFUoHB4bErPuF9I8NazCfmy-7DpDfZvSTHvgqUogtSKYEI-wXf_66KPO7GkoIfN-wqdV9tNCmYe0FsEHvqEvEZ5tfdiPGRmltLJYx7xlhx1_4Z3ZFzfbvP35GCjth8spO4Be626ig
link.rule.ids 315,782,786,27935,27936
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Exploratory+Pilot+Study+of+Neuropsychological+Performance+in+Two+Huntington+Disease+Centers+of+Excellence+Clinics&rft.jtitle=Archives+of+clinical+neuropsychology&rft.au=Rossetti%2C+M+Agustina&rft.au=Anderson%2C+Kendra+M&rft.au=Hay%2C+Kaitlyn+R&rft.au=Del+Bene%2C+Victor+A&rft.date=2024-01-19&rft.pub=Oxford+University+Press&rft.eissn=1873-5843&rft.volume=39&rft.issue=1&rft.spage=24&rft.epage=34&rft_id=info:doi/10.1093%2Farclin%2Facad054&rft.externalDocID=10.1093%2Farclin%2Facad054
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1873-5843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1873-5843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1873-5843&client=summon